Evidence map›Paper›PMID 38922132›Full record

ArticleToxins2024

Sensitive Detection and Differentiation of Biologically Active Ricin and Abrin in Complex Matrices via Specific Neutralizing Antibody-Based Cytotoxicity Assay.

Zhi Li, Bo Ma, Mengqiang Gong, Lei Guo, Lili Wang, Hua Xu, Jianwei Xie

Abstract read
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhi LiLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.
Bo MaLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.
Mengqiang GongLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.
Lei GuoLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.ORCID 0000-0003-4780-712X
Lili WangLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.
Hua XuLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.
Jianwei XieLaboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing 100850, China.

Funding

National Natural Science Foundation of China 21974151the Key Project of National Key Research and Development Program 2018YFC1602600
6 · The paper itself

Abstract

Ricin and abrin are highly potent plant-derived toxins, categorized as type II ribosome-inactivating proteins. High toxicity, accessibility, and the lack of effective countermeasures make them potential agents in bioterrorism and biowarfare, posing significant threats to public safety. Despite the existence of many effective analytical strategies for detecting these two lethal toxins, current methods are often hindered by limitations such as insufficient sensitivity, complex sample preparation, and most importantly, the inability to distinguish between biologically active and inactive toxin. In this study, a cytotoxicity assay was developed to detect active ricin and abrin based on their potent cell-killing capability. Among nine human cell lines derived from various organs, HeLa cells exhibited exceptional sensitivity, with limits of detection reaching 0.3 ng/mL and 0.03 ng/mL for ricin and abrin, respectively. Subsequently, toxin-specific neutralizing monoclonal antibodies MIL50 and 10D8 were used to facilitate the precise identification and differentiation of ricin and abrin. The method provides straightforward and sensitive detection in complex matrices including milk, plasma, coffee, orange juice, and tea via a simple serial-dilution procedure without any complex purification and enrichment steps. Furthermore, this assay was successfully applied in the unambiguous identification of active ricin and abrin in samples from OPCW biotoxin exercises.

Indexed as

AbrinAntibodies, NeutralizingRicinAnimalsAntibodies, MonoclonalHumansAbrinAntibodies, MonoclonalAntibodies, NeutralizingRicinabrinactivitycomplex matricescytotoxicity assayneutralizing antibodyricin

Identifiers

PMID38922132
PMCPMC11209497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.